NASDAQ: UPB
Upstream Bio Inc Stock Ownership - Who owns Upstream Bio?

Insider buying vs selling

Have Upstream Bio Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Ai Upstream LLC10% Owner2024-10-151,175,000$17.00
$19.98MBuy
Erez ChimovitsDirector2024-10-15660,000$17.00
$11.22MBuy
Erez ChimovitsDirector2024-10-15165,000$17.00
$2.81MBuy
Orbimed Advisors LLCDirector2024-10-15660,000$17.00
$11.22MBuy
Orbimed Advisors LLCDirector2024-10-15165,000$17.00
$2.81MBuy

1 of 1

UPB insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when UPB insiders and whales buy or sell their stock.

UPB Shareholders

What type of owners hold Upstream Bio Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC13.49%7,255,859$82.43MInstitution
Erez Chimovits10.81%5,813,673$66.04MInsider
Orbimed Advisors LLC10.81%5,813,673$66.04MInsider
Orbimed Advisors LLC10.58%5,693,589$64.68MInstitution
Ai Upstream LLC10.21%5,494,410$62.42MInsider
Decheng Capital LLC6.11%3,285,293$37.32MInstitution
Altshuler Shaham Ltd6.01%3,235,293$36.75MInstitution
Tcg Crossover Management LLC5.21%2,801,763$31.83MInstitution
Enavate Sciences GP LLC4.57%2,459,703$27.94MInstitution
Deep Track Capital LP4.27%2,299,567$26.12MInstitution

1 of 3

UPB vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
UPB71.55%28.45%Net Buying
TRVI32.51%67.49%Net BuyingNet Buying
EYPT27.22%72.78%Net SellingNet Selling
STOK51.40%48.60%Net SellingNet Selling
BCAX69.70%30.30%Net Buying

Upstream Bio Stock Ownership FAQ

Who owns Upstream Bio?

Upstream Bio (NASDAQ: UPB) is owned by 84.23% institutional shareholders, 33.49% Upstream Bio insiders, and 0.00% retail investors. Erez Chimovits is the largest individual Upstream Bio shareholder, owning 5.81M shares representing 10.81% of the company. Erez Chimovits's Upstream Bio shares are currently valued at $66.04M.

If you're new to stock investing, here's how to buy Upstream Bio stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.